B Braun Medical Inc. is recalling approximately 43.6 million units of Streamline Airless System Hemodialysis Bloodlines across seven different models used in dialysis treatments. The recall was initiated because the patient connector may not fully insert into the 'Locksite' port, which can prevent the internal valve from opening completely. This defect can block the flow of blood during cleaning procedures, potentially causing therapy delays or forcing medical staff to switch to alternative flow methods. This recall affects all unexpired lots of the listed Streamline models distributed nationwide.
If the patient connector is not fully inserted, the internal seal may restrict or block blood flow during the rinseback process. This can lead to significant delays in vital hemodialysis therapy while clinicians are forced to troubleshoot the equipment or switch to a retrograde flow method.
Manufacturer consultation and therapy adjustment
“Label, 0.9% Sodium Chloride for Injection USP 1000 mL in E3 containers”
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.